Código QR (código de barras bidimensional)

CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE

Aim. To study the use of CYP2C19 pharmacogenetic testing (PhGT) for personalization of antiplatelet therapy in patients with acute coronary syndrome (ACS) in routine practice.Material and methods. The study included 103 patients with ACS without indications for long-term anticoagulant therapy, which...

ver descrição completa

Na minha lista:
Principais autores: A. I. Akhmetova, E. B. Kleimenova, D. A. Sychev, O. V. Parshina, L. P. Yashina
Formato: Artigo
Idioma:Inglês
Publicado em: Столичная издательская компания 2017-12-01
coleção:Рациональная фармакотерапия в кардиологии
Assuntos:
acute coronary syndrome
pharmacogenetics
cyp2c19
clopidogrel
ticagrelor
clinical guidelines
Acesso em linha:https://www.rpcardio.online/jour/article/view/1564
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados